
A malaria vaccine price deal could protect up to one million more children.
The planned 40% price cut could save about $50 million over three years.
Every serving. No expiration date.

The planned 40% price cut could save about $50 million over three years.

Nature restoration is scaling—and already supporting more than one million green jobs.

The rule targets excessive distribution markups while requiring manufacturers to maintain supply.

Economic security and rainforest stewardship rose together in three Indigenous communities—but the pilot had no control group.

The 3,200 km² sanctuary was officially opened in December 2025. An October 2026 report describes subsequent fence removal and wider habitat work.

Conservation funding is moving onto farms with producer contracts attached.

A school-leaving law became rare causal evidence that social policy can shape brain health decades later.

A few strategically bare loops replaced a forest of compromises.

Child care relief is moving from pilot to citywide scale.

The lab bench is moving onto working farms.

A more precise signal gave exhausted treatment paths one more opening.

Stable housing, VA care and support services are being built together.

Old fishing gear came out. Data, habitat and coastal jobs moved in.

A local law turns a family-support promise into paid time.

A parent-led preschool and Spanish-immersion campaign helped Daniel Webster Elementary grow into a thriving neighborhood school.

The system reasoned through 304 difficult cases step by step, but the result is still a benchmark—not patient care.

A circuit map hints that plasticity and hallucination may not be inseparable.

One tumor. One recipe. A 42% lower relative risk.

One positron. Months of control. A new precision tool for fundamental physics.

A narrow passage in a 150-mile migration just got durable protection.

A new name for a landscape protected since 1924.

Exercise kept the heart inside the Mars envelope.

Housing stability may be health care.

In trials, 24% met treatment-stopping criteria versus none on placebo; 19% stayed controlled 24 weeks after stopping all therapy.